Seth Meyers is an honest man, but he can speak the prevaricating lingo of the Republicans, also known as big lies. When HHS Secretary Tom Price or Senator Bill Cassidy (R-LA) spin the latest version of the “health care bill,” Meyers translates those whoppers with ease. (Cassidy’s slippery defense of the Senate bill is especially […]
With Democrats desperate for signs of hope after Hillary Clinton’s loss, Jon Ossoff’s underdog “Make Trump Furious” campaign has endeared him to national anti-Trump activists and pushed him well ahead of 17 rivals in polls.
Price invested about $10,000 in 2015 and another $50,000 to $100,000 in the company last summer, records show. He appears to have sold all those shares on two days in February, reaping between $265,000 and $550,000, according to forms he filed last month with the federal Office of Government Ethics.
On the same day the stockbroker for then-Georgia Congressman Tom Price bought him up to $90,000 of stock in six pharmaceutical companies last year, Price arranged to call a top U.S. health official, seeking to scuttle a controversial rule that could have hurt the firms’ profits and driven down their share prices, records obtained by ProPublica show.
Tom Price, head of the Department of Health and Human Services, came under scrutiny during his confirmation hearings for investments he made while serving in Congress. The Georgia lawmaker traded hundreds of thousands of dollars worth of shares in health-related companies, even as he voted on and sponsored legislation affecting the industry.
Things quickly devolved, as he struggled to defend the bill’s tax breaks for the wealthy and its rollback of Medicaid expansion. In one especially galling sequence, Price all but dismissed a cancer survivor’s concerns about the elimination of his coverage.
Unlike appointees exposed to the scrutiny of the Senate, members of these so-called “beachhead teams” have operated largely in the shadows, with the White House declining to publicly reveal their identities.
If Trump and Congress repeal Obamacare’s individual mandate and subsidies while leaving insurance market reforms in place, 32 million Americans, many of whom are Medicaid recipients, will lose their health coverage over the next 10 years.
If the outrage in the streets and town halls is matched by a stunning electoral defeat in Tom Price’s Georgia district, it could put the fear of getting gnawed at the polls in the mind of the Republicans who represent swing states.
The Senate voted 52-47 on Friday to confirm Representative Tom Price as the top U.S. healthcare official, putting a determined opponent of Obamacare in position to help President Donald Trump dismantle the healthcare law. Price, in his new job, will have authority to rewrite rules implementing the 2010 Affordable Care Act.
From cutting off free birth control for women to tightening the eligibility rules for mid-year health insurance enrollees, Price — once confirmed as secretary of Health and Human Services — will be able to tinker around the edges of the 2010 law. And that gives Republican lawmakers a bit more time to find consensus on their repeal-and-replace effort.
“We’re going to have insurance for everybody,” Donald Trump told The Washington Post a few days before he was sworn in. You can bet no one has any idea what that actually means. That includes Rep. Tom Price (R-GA), Trump’s nominee for secretary of health and human services, who dodged details at a confirmation hearing on Tuesday. It also includes Trump, who has yet to demonstrate that he actually knows what’s in the Affordable Care Act, let alone how he would replace it.
Democrats stayed away from the meeting for a second day running, which under the committee’s rules normally would have prevented the votes from taking place. But Republicans voted to suspend the rule that had required at least one Democrat to be present for business to be conducted, sending the nominations to the full Senate for a vote.
Senate Democrats said they were postponing the vote because they wanted more information on Price’s stock trades in an Australian medical company and needed more details on reports that Mnuchin’s former bank, OneWest, used automated “robo-signings” of foreclosure documents, which contradicted statements the nominees had made to senators.
CNN reported on Sunday that Rep. Price bought between $1,001 and $15,000 worth of shares last March in Zimmer Biomet Holdings Inc., a medical device manufacturer. Days later, he introduced legislation in the House of Representatives that would have delayed a regulation that could have ultimately damaged the company, CNN said.
CNN reported on Sunday that Price bought between $1,001 and $15,000 worth of shares last March in Zimmer Biomet Holdings Inc, a medical device manufacturer. Days later, he introduced legislation to the House of Representatives that would have delayed a regulation that could have ultimately damaged the company.
Price reportedly bought and sold more than $300,000 in stock in about 40 healthcare, pharmaceutical and biomedical companies over the past four years while sponsoring and advocating legislation that could influence those companies’ shares.
Back when the president’s health reform plan first passed, Republicans and their media echoes warned loudly about mythical “death panels” embedded in his legislation. Now, the voters who believed that nonsense are about to meet the real death panel — led by Speaker Paul Ryan, Senate leader Mitch McConnell, and Rep. Tom Price, the Georgia Republican slated to head the Department of Health and Human Services.
In Trump’s picks for economic and domestic policymaking jobs, there’s a consistent underlying thread. Most of them could have been nominated by any GOP nominee. There’s nary a populist among them — not even the conservative kind.
It’s beginning to look like Donald Trump does not know how this whole president-ing thing works. And since he has the curiosity level of a pet rock, chances don’t seem great that he’ll be learning anytime soon.
Jeff Danziger’s award-winning drawings, syndicated by the Washington Post Writers Group, are published by more than 600 newspapers and websites. He has been a cartoonist for the Rutland Herald, the New York Daily News and the Christian Science Monitor; his work has appeared in newspapers from the Wall Street Journal to Le Monde and Izvestia. He […]